{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:40:02Z","timestamp":1714059602567},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,7,25]],"date-time":"2000-07-25T00:00:00Z","timestamp":964483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,7,25]],"date-time":"2000-07-25T00:00:00Z","timestamp":964483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/cvm-1-1-009","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Debate: Unstable angina - When should we intervene?"],"prefix":"10.1186","volume":"1","author":[{"given":"Dean J","family":"Kereiakes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,25]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","volume":"338","author":"WE Boden","year":"1998","unstructured":"Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW: Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive, as compared with a conservative, management strategy. N Engl J Med. 1998, 338: 1785-1792. 10.1056\/NEJM199806183382501.","journal-title":"N Engl J Med"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","volume":"26","author":"HV Anderson","year":"1995","unstructured":"Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud EL, Thompson B, Willerson JT, Braunwald E: One year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial; a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995, 26: 1643-1650. 10.1016\/0735-1097(95)00404-1.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"33G","DOI":"10.1016\/S0002-9149(88)80030-4","volume":"61","author":"GO Hartzler","year":"1988","unstructured":"Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV: ''High risk'' percutaneous transluminal coronary angioplasty. Am J Cardiol. 1988, 61: 33G-37G.","journal-title":"Am J Cardiol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0735-1097(97)00512-3","volume":"31","author":"C Adele","year":"1998","unstructured":"Adele C, Vaitkus PT, Wells SW, Zehnacker JB: Cost advantages of an ad hoc angioplasty strategy. J Am Coll Cardiol. 1998, 31: 321-325. 10.1016\/S0735-1097(97)00512-3.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR5","first-page":"88","volume":"82 (suppl)","author":"RK Myler","year":"1990","unstructured":"Myler RK, Shaw RE, Stertzer SH, Bashour TT, Ryan C, Hecht HS: Unstable angina and coronary angioplasty. Circulation . 1990, 82 (suppl): 88-95.","journal-title":"Circulation"},{"key":"1_CR6","volume-title":"Rockville, MD: Agency for health care policy and research and the National Heart, Lung and Blood Institute, Public Health Service. U.S. Department of Health and Human Services; AHCPR Publication No. 94-0602","author":"E Braunwald","year":"1994","unstructured":"Braunwald E, Mark DB, Jones RH, Cheitlin MD, Fuster V, McCauley KM, Edwards C, Green LA, Mushlin AI, Swain JA, Smith EE, Cowan M, Rose GC, Concannon CA, Grines CL, Brown L, Lytle BW, Goldman L, Topol EJ, Willerson JT, Brown J, Archibald N: Unstable Angina: Diagnosis and Management. Rockville, MD: Agency for health care policy and research and the National Heart, Lung and Blood Institute, Public Health Service. U.S. Department of Health and Human Services; AHCPR Publication No. 94-0602 . 1994"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1161\/01.CIR.90.4.1631","volume":"90","author":"The Global Use of Strategies to Ope","year":"1994","unstructured":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators: : Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation. 1994, 90: 1631-1637.","journal-title":"Circulation"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"M Cohen","year":"1997","unstructured":"Cohen M, Demers C, Garfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F: A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997, 337: 447-452. 10.1056\/NEJM199708143370702.","journal-title":"N Engl J Med"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"The Platelet Receptor Inhibition in","year":"1998","unstructured":"The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators: : Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 1998, 338: 1488-1497. 10.1056\/NEJM199805213382102.","journal-title":"N Engl J Med"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The PURSUIT Trial investigators:","year":"1998","unstructured":"The PURSUIT Trial investigators: : Inhibition of platelet glycoprotein llb\/llla with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998, 339: 436-443. 10.1056\/NEJM199808133390704.","journal-title":"N Engl J Med"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","volume":"97","author":"The PARAGON Investigators:","year":"1998","unstructured":"The PARAGON Investigators: : International, randomized, controlled trial of lamfiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. Circulation. 1998, 97: 2386-2395.","journal-title":"Circulation"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/S0735-1097(98)00140-5","volume":"31","author":"RT van Domburg","year":"1998","unstructured":"van Domburg RT, Miltenburg-vanZijl AJ, Veerhoek RJ, Simoons ML: Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol. 1998, 31: 1534-1539. 10.1016\/S0735-1097(98)00140-5.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(97)11162-X","volume":"352","author":"S Yusuf","year":"1998","unstructured":"Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuzynski L: Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998, 352: 507-514. 10.1016\/S0140-6736(97)11162-X.","journal-title":"Lancet"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0002-8703(99)70071-2","volume":"138","author":"BM Scirica","year":"1999","unstructured":"Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aquirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Cannon CP: Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry. Am Heart J. 1999, 138: 1065-1072.","journal-title":"Am Heart J"},{"key":"1_CR15","volume-title":"Eur Heart J","author":"KA Fox","year":"2000","unstructured":"Fox KA, Kokkinos DV, Deckers J, Keil U, Maggioni A, Steg G: The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J. 2000."},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0735-1097(96)00447-0","volume":"29","author":"B Lindahl","year":"1997","unstructured":"Lindahl B, Venge P, Wallentin L: Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol. 1997, 29: 43-48. 10.1016\/S0735-1097(96)00447-0.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"EM Antiman","year":"1999","unstructured":"Antiman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Bruamwald E: Enoxaparin prevents death and cardiac Ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) IIb trial. Circulation. 1999, 100: 1593-1601.","journal-title":"Circulation"},{"key":"1_CR18","doi-asserted-by":"crossref","unstructured":"Fragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators: Long-term low molecular mass heparin in unstable coronary-artery disease. Lancet. 1999, 354: 701-707. 10.1016\/S0140-6736(99)07350-X.","DOI":"10.1016\/S0140-6736(99)07350-X"},{"key":"1_CR19","doi-asserted-by":"crossref","unstructured":"Fragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease. Lancet . 1999, 354: 708-715. 10.1016\/S0140-6736(99)07349-3.","DOI":"10.1016\/S0140-6736(99)07349-3"},{"key":"1_CR20","first-page":"I","volume":"100","author":"JP Collett","year":"1999","unstructured":"Collett JP, Montalescot G, Probinski G, Tanagano F, Lison L, Annick A, Sotirov I, Choussat R, Thomas D: PTCA without heparin and without coagulation monitoring in unstable angina patients pre-treated with subcutaneous enoxaparin [abstract]. Circulation. 1999, 100: I-188.","journal-title":"Circulation"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"CAPTURE Investigators:","year":"1997","unstructured":"CAPTURE Investigators: : Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet. 1997, 349: 1429-1435. 10.1016\/S0140-6736(96)10452-9.","journal-title":"Lancet"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","volume":"100","author":"E Boersma","year":"1999","unstructured":"Boersma E, Akkerhuis M, Theroux P, Califf RM, Topol EJ, Simoons ML: Platelet glycoprotein IIb\/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes. Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999, 100: 2045-2048.","journal-title":"Circulation"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/01.CIR.101.7.751","volume":"201","author":"NS Kleiman","year":"2000","unstructured":"Kleiman NS, Lincoff AM, Flaker GC, Pieper KS, Wilcox RG, Berdan LG, Lorenz TJ, Cokkinos DV, Simoons ML, Boersma E, Topol EJ, Califf RM, Harrington RA: Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. Circulation . 2000, 201: 751-757.","journal-title":"Circulation"},{"key":"1_CR24","first-page":"29A","volume":"33","author":"M Singh","year":"1999","unstructured":"Singh M, Holmes DR, Garratt KN, Bell MR, Berger PB, Rihal CS, Schwartz RS, Hammes L: Stents versus conventional PTCA in unstable angina [abstract]. J Am Coll Cardiol. 1999, 33: 29A-","journal-title":"J Am Coll Cardiol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"100A","DOI":"10.1016\/S0735-1097(97)84141-1","volume":"31","author":"M Angioi","year":"1998","unstructured":"Angioi M, Danchin N, Gangloff C, Grentzinger A, Jacquemin L, Berder V, Houplon P, Julliere Y, Cherrier F: Ticlopidine-aspirin as antithrombotic regimen for intracoronary stenting for unstable angina: is there a need for further antiplatelet therapy? [abstract]. J Am Coll Cardiol. 1998, 31: 100A-10.1016\/S0735-1097(97)84141-1.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0735-1097(98)00334-9","volume":"32","author":"A Kastrati","year":"1998","unstructured":"Kastrati A, Neumann FJ, Schomig A: Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol . 1998, 32: 970-978. 10.1016\/S0735-1097(98)00334-9.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR27","first-page":"I","volume":"94(suppl I)","author":"Y Lu","year":"1996","unstructured":"Lu Y, Theroux P, Xiao Z, Ghitescu M: Increased expression of GP IIb\/IIIa platelet membrane receptor in acute ischemic syndromes [abstract]. Circulation. 1996, 94(suppl I): I-515.","journal-title":"Circulation"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/euhj.1997.0747","volume":"19","author":"L Pizulli","year":"1998","unstructured":"Pizulli L, Yang A, Martin JF, Luderitz B: Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998, 19: 80-84. 10.1053\/euhj.1997.0747.","journal-title":"Eur Heart J"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","volume":"33","author":"KA Ault","year":"1999","unstructured":"Ault KA, Cannon CP, Mitchell J, McCahan J, Tracy RP, Novotny WF, Reimann JD, Braunwald E: Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. J Am Coll Cardiol. 1999, 33: 634-639. 10.1016\/S0735-1097(98)00635-4.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0735-1097(97)00110-1","volume":"30","author":"AM Lincoff","year":"1997","unstructured":"Lincoff AM, Califf RM, Anderson KM, Weisman HF, Aguirre FV, Kleiman NS, Harrington RA, Topol EJ: Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb\/IIIa receptor blockade by abciximab (7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol. 1997, 30: 149-156. 10.1016\/S0735-1097(97)00110-1.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(99)10018-7","volume":"354","author":"EJ Topol","year":"1999","unstructured":"Topol EJ, Mark DB, Lincoff AM, Cohen E, Burton J, Kleiman N, Talley D, Sapp S, Booth J, Cabot CF, Anderson K, Califf RM: Outcomes of 1 year and economic implications of platelet IIb\/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. Lancet. 1999, 354: 2019-2024. 10.1016\/S0140-6736(99)10018-7.","journal-title":"Lancet"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","volume":"278","author":"EJ Topol","year":"1997","unstructured":"Topol EJ, Ferguson JJ, Weisman HF, Tcheng JE, Ellis SG, Kleiman NS, Ivanhoe RJ, Wang AL, Miller DP, Anderson KM, Califf RM: Long-term protection from myocardial ischemic events in a randomized trial of brief integrin \u03b2 3 blockade with percutaneous coronary intervention. JAMA. 1997, 278: 479-484. 10.1001\/jama.278.6.479.","journal-title":"JAMA"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0002-9149(00)00696-2","volume":"85","author":"DL Bhatt","year":"2000","unstructured":"Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ: The benefit of abciximab in interventional cardiology is not device-specific. Am J Cardiol. 2000, 85: 1060-1064. 10.1016\/S0002-9149(00)00696-2.","journal-title":"Am J Cardiol"},{"key":"1_CR34","first-page":"571","volume":"19","author":"DF Kong","year":"1998","unstructured":"Kong DF, Hasselblad V, Tcheng JE, Ohman EM, Topol EJ, Califf RM: Clinical outcome improvements from coronary stenting a systematic overview [abstract]. Eur Heart J. 1998, 19: 571-","journal-title":"Eur Heart J"},{"key":"1_CR35","first-page":"12A","volume":"35","author":"AK Jacobs","year":"2000","unstructured":"Jacobs AK, Laskey WK, Vlachos H, Cowley MJ, Faxon DP, Williams DO, Detre KM: Outcome of patients undergoing coronary intervention at the time of diagnostic catheterization: A report from the 1999 Dynamic Registry [abstract]. J Am Coll Cardiol. 2000, 35: 12A-","journal-title":"J Am Coll Cardiol"},{"key":"1_CR36","first-page":"39A","volume":"35","author":"DO Williams","year":"2000","unstructured":"Williams DO, Yeh W, Detre KM, Kelsey SF, Cohen H, Cowley MJ, Al-Bassam M, Jacobs AK, Bourassa M: Percutaneous coronary intervention for non-ST elevation myocardial infarction: a report from the NHLBI Dynamic Registry [abstract]. J Am Coll Cardiol. 2000, 35: 39A-","journal-title":"J Am Coll Cardiol"},{"key":"1_CR37","first-page":"347A","volume":"35","author":"V Menon","year":"2000","unstructured":"Menon V, Homel P, Kamel SM, Fincke R, Swistel DG, Hochman JS: Mortality with coronary artery bypass grafting for non Q MI; results from the 1996 New York State Cardiac Surgery database [abstract]. J Am Coll Cardiol. 2000, 35: 347A-","journal-title":"J Am Coll Cardiol"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"49E","DOI":"10.1016\/S0002-9149(98)00198-2","volume":"81","author":"DJ Kereiakes","year":"1998","unstructured":"Kereiakes DJ: Preferential benefit of platelet glycoprotein IIb\/IIIa receptor blockade: specific considerations by device and disease state. Am J Cardiol. 1998, 81: 49E-54E. 10.1016\/S0002-9149(98)00198-2.","journal-title":"Am J Cardiol"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1067\/mhj.2000.103741","volume":"139 (suppl)","author":"DJ Kereiakes","year":"2000","unstructured":"Kereiakes DJ, McDonald M, Broderick TB, Roth EM, Whang DD, Martin LH, Howard WL, Schneider J, Shimshak T, Abbottsmith CW: Platelet glycoprotein IIb\/IIIa receptor blockers: an appropriate use model for expediting care in acute coronary syndromes. Am Heart J. 2000, 139 (suppl): S53-S60. 10.1067\/mhj.2000.103741.","journal-title":"Am Heart J"},{"key":"1_CR40","first-page":"41A","volume":"33","author":"RJ Lundstrom","year":"1999","unstructured":"Lundstrom RJ, Colby CJ, Jindeel A, Hay RL: Abciximab in unstable coronary syndromes: benefits and costs in a group model non-profit health maintenance organization [abstract]. J Am Coll Cardiol. 1999, 33: 41A-","journal-title":"J Am Coll Cardiol"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0735-1097(99)00643-9","volume":"35","author":"GS Scull","year":"2000","unstructured":"Scull GS, Martin JS, Weaver D, Every NR: Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction. J Am Coll Cardiol . 2000, 35: 895-902. 10.1016\/S0735-1097(99)00643-9.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","volume":"335","author":"EM Ohman","year":"1996","unstructured":"Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996, 335: 1333-1341. 10.1056\/NEJM199610313351801.","journal-title":"N Engl J Med"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","volume":"335","author":"EM Antman","year":"1996","unstructured":"Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996, 335: 1342-1349. 10.1056\/NEJM199610313351802.","journal-title":"N Engl J Med"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1161\/01.CIR.98.18.1831","volume":"98","author":"R Roberts","year":"1998","unstructured":"Roberts R, Fromm RE: Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Circulation. 1998, 98: 1831-1833.","journal-title":"Circulation"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/01.CIR.93.9.1651","volume":"93","author":"B Lindahl","year":"1996","unstructured":"Lindahl B, Venge P, Wallentin L: Relation between troponin T and the risk of subsequent caridac events in unstable coronary artery disease. Circulation. 1996, 93: 1651-1657.","journal-title":"Circulation"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","volume":"340","author":"CW Hamm","year":"1999","unstructured":"Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, et al: Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999, 340: 1623-1629. 10.1056\/NEJM199905273402103.","journal-title":"N Engl J Med"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","volume":"354","author":"C Heeschen","year":"1999","unstructured":"Heeschen C, Hamm CS, Goldmann B, Deu A, Langenbrink L, White HD: Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators: Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet. 1999, 354: 1757-1762. 10.1016\/S0140-6736(99)10285-X.","journal-title":"Lancet"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0002-9149(99)00319-7","volume":"84","author":"TA Hyde","year":"1999","unstructured":"Hyde TA, French JK, Wong CK, Strazinicky IT, Whitlock RM, White HD: Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. Am J Cardiol. 1999, 84: 379-385. 10.1016\/S0002-9149(99)00319-7.","journal-title":"Am J Cardiol"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/hj.1999.v137.93029","volume":"137","author":"O Bazzino","year":"1999","unstructured":"Bazzino O, Diaz R, Tajer C, Paviottic , Mele E, Trivi M, Piombo A, Prado AH, Paolasso E: Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. Am Heart J . 1999, 137: 322-331.","journal-title":"Am Heart J"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/000331979704800801","volume":"48","author":"M Owa","year":"1997","unstructured":"Owa M, Origasa H, Saito M: Predictive validity of the Braunwald classification of unstable angina for angiographic findings, short-term prognoses, and treatment selection. Angiology. 1997, 48: 663-671.","journal-title":"Angiology"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0735-1097(96)00560-8","volume":"29","author":"G Dangas","year":"1997","unstructured":"Dangas G, Mehran R, Wallenstein S, Courcoutsakis NA, Kakarala V, Hollywood J, Ambrose JA: Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol. 1997, 29: 519-525. 10.1016\/S0735-1097(96)00560-8.","journal-title":"J Am Coll Cardiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-1-1-009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cvm-1-1-009\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-1-1-009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:06:46Z","timestamp":1714057606000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/cvm-1-1-009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2000,4]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1186\/cvm-1-1-009","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,25]]},"assertion":[{"value":"1 May 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"9"}}